A definitive answer on whether there is an increased risk of pancreatic cancer with incretin diabetes drugs is still some years away, said dozens of experts at the NIDDK this week.

As a consequence of their different mechanisms of action, the glucose-lowering effects of DPP-4 inhibitors are observed to be less than those of the GLP-1 receptor agonists. Under similar ...

GLP-1 and GIP are known as incretins. While both GLP-1 and GIP are required to maintain normal blood glucose levels in healthy subjects, incretins in patients with type-2 diabetes (T2D) don't ...

Type 2 diabetes mellitus (T2DM) is a huge health problem globally. It affects nearly 25.8 million people in the United States. 1 Over 35% of US adults 20 years or older (or 79 million Americans ...

A retrospective analysis of evidence from prescription data gathered in Belgium and Italy has found that uncontrolled diabetes might be an early sign of pancreatic cancer.

Gastric bypass surgery (GBP) results in important and sustained weight loss and remarkable improvement of Type 2 diabetes. The favorable change in the incretin gut hormones is thought to be ...

A group of British diabetologists has backed the use of glucagon-like peptide (GLP)-1 based therapies in some patients with diabetes, refuting concerns the drugs may be linked with pancreatic adverse ...

Incretins are hormones secreted by intestinal cells that regulate pancreatic insulin and glucagon to control sugar metabolism in mammals. Although counterparts of insulin and glucagon have been ...